Brief: Theravance Biopharma Q4 Operating Income USD -9.2 Million
26/02/2025 21:05
Feb 26 (Reuters) - Theravance Biopharma Q4 adjusted net income USD -2.472 million. Q4 net income USD -15.528 million
Recent news on Theravance Biopharma
See all newsIreland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth
Ireland's Theravance Biopharma Q4 revenue misses expectations
Corrected: BRIEF-Theravance Biopharma Q4 Operating Income USD 20.012 Million
U.S. STOCKS ON THE MOVE-Versant Media Group, Lithium miners, Expedia Group
U.S. STOCKS ON THE MOVE-Expedia Group, Blue Owl Capital, Enphase Energy